HLA Class II Genes Interact with the Immune Correlates from the RV144 Vaccine Efficacy Trial and Impact HIV-1 Acquisition

被引：0
|
作者：
Prentice, H. [7 ]
Geraghty, D. E. [1 ]
Tomaras, G. D. [2 ]
Fong, Y. [1 ]
Nelson, W. [1 ]
Kijak, G. H. [7 ]
Zolla-Pazner, S. [3 ]
Nitayaphan, S. [4 ]
Rerks-Ngarm, S. [5 ]
Kaewkungwal, J. [6 ]
Pitisuttithum, P. [6 ]
Gilbert, P. B. [1 ]
Haynes, B. F. [2 ]
Kim, J. H. [7 ]
Michael, N.
Thomas, R.
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] NYU, Sch Med, New York, NY USA
[4] US Army Med Component, AFRIMS, Bangkok, Thailand
[5] Minist Publ Hlth, Nonthanburi, Thailand
[6] Mahidol Univ, Bangkok 10700, Thailand
[7] US MHRP, Silver Spring, MD USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2013年 / 29卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A178 / A178
页数：1
相关论文
共 50 条
  • [41] Complex immune correlates of protection in HIV-1 vaccine efficacy trials
    Tomaras, Georgia D.
    Plotkin, Stanley A.
    IMMUNOLOGICAL REVIEWS, 2017, 275 (01) : 245 - 261
  • [42] Role of Vaccine-induced V2 Antibodies in Protection from HIV Infection of Recipients in the RV144 Clinical Vaccine Trial
    Zolla-Pazner, Susan
    Williams, Constance
    deCamp, Allan
    Morris, Daryl
    Haynes, Barton
    Kim, Jerome
    Michael, Nelson
    Rao, Mangala
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 : 46 - 46
  • [43] Investigation of Antibody Responses Induced in RV305 a Late Boost Vaccination of HIV-1 Uninfected Volunteers that Participated in RV144, a Thai Trial
    Karasavvas, N.
    Karnasuta, C.
    Ngauy, V.
    Vasan, S.
    Trichavaroj, R.
    de Souza, M. S.
    Savadsuk, H.
    Inthawong, D.
    Rittiroongrad, S.
    Madnote, S.
    Nitayaphan, S.
    Pitisuttithum, P.
    Rerks-Ngarm, S.
    O'Connell, R. J.
    Michael, N. L.
    Kim, J. H.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A166 - A166
  • [44] Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates
    Tomaras, Georgia D.
    Haynes, Barton F.
    VACCINES, 2014, 2 (01): : 15 - 35
  • [45] Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
    Gottardo, Raphael
    Bailer, Robert T.
    Korber, Bette T.
    Gnanakaran, S.
    Phillips, Joshua
    Shen, Xiaoying
    Tomaras, Georgia D.
    Turk, Ellen
    Imholte, Gregory
    Eckler, Larry
    Wenschuh, Holger
    Zerweck, Johannes
    Greene, Kelli
    Gao, Hongmei
    Berman, Phillip W.
    Francis, Donald
    Sinangil, Faruk
    Lee, Carter
    Nitayaphan, Sorachai
    Rerks-Ngarm, Supachai
    Kaewkungwal, Jaranit
    Pitisuttithum, Punnee
    Tartaglia, James
    Robb, Merlin L.
    Michael, Nelson L.
    Kim, Jerome H.
    Zolla-Pazner, Susan
    Haynes, Barton F.
    Mascola, John R.
    Self, Steve
    Gilbert, Peter
    Montefiori, David C.
    PLOS ONE, 2013, 8 (09):
  • [46] HIV-1-specific IgG antibody levels correlate with the presence of a specific HLA class II allele to impact acquisition and vaccine efficacy
    Prentice, Heather
    Tomaras, Georgia
    Geraghty, Daniel
    Apps, Richard
    Fong, Youyi
    Ehrenberg, Philip
    Rolland, Morgane
    Kijak, Gustavo
    Nelson, Wyatt
    Decamp, Allan
    Shen, Xiaoying
    Yates, Nicole
    Zolla-Pazner, Susan
    Nitayaphan, Sorachai
    Rerks-Ngarm, Supachai
    Pitisuttithum, Punnee
    Ferrari, Guido
    Montefiori, David
    McElrath, Juliana
    Bailer, Robert
    Koup, Richard
    O'Connell, Robert
    Robb, Merlin
    Michael, Nelson
    Kim, Jerome
    Thomas, Rasmi
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
  • [47] Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations
    Akapirat, Siriwat
    Karnasuta, Chitraporn
    Vasan, Sandhya
    Rerks-Ngarm, Supachai
    Pitisuttithum, Punnee
    Madnote, Sirinan
    Savadsuk, Hathairat
    Rittiroongrad, Surawach
    Puangkaew, Jiraporn
    Phogat, Sanjay
    Tartaglia, James
    Sinangil, Faruk
    de Souza, Mark S.
    Excler, Jean-Louis
    Kim, Jerome H.
    Robb, Merlin L.
    Michael, Nelson L.
    Ngauy, Viseth
    O'Connell, Robert J.
    Karasavvas, Nicos
    PLOS ONE, 2018, 13 (04):
  • [48] The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope
    de Souza, Mark S.
    Ratto-Kim, Silvia
    Chuenarom, Weerawan
    Schuetz, Alexandra
    Chantakulkij, Somsak
    Nuntapinit, Bessara
    Valencia-Micolta, Anais
    Thelian, Doris
    Nitayaphan, Sorachai
    Pitisuttithum, Punnee
    Paris, Robert M.
    Kaewkungwal, Jaranit
    Michael, Nelson L.
    Rerks-Ngarm, Supachai
    Mathieson, Bonnie
    Marovich, Mary
    Currier, Jeffrey R.
    Kim, Jerome H.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (10): : 5166 - 5176
  • [49] A helical structure in the V2 domain of gp120 that localizes to the site of immune pressure in the RV144 vaccine trial is conserved in HIV and SIV envelopes
    Lertjuthaporn, S.
    Cicala, C.
    Van Ryk, D.
    Yolitz, J.
    Wei, D.
    Gorini, G.
    Franchini, G.
    Roederer, M.
    Mason, R.
    Pattanapanyasat, K.
    Kong, X. -P.
    Wibmer, K.
    Morris, L.
    Fauci, A. S.
    Arthos, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 20 - 20
  • [50] HLA CLASS II GENES CORRELATE WITH PROTECTIVE NEUTRALIZING ANTIBODY TITERS IN A DENGUE VACCINE EFFICACY TRIAL
    Geretz, Aviva
    Shangguan, Shida
    Bryant, Chris
    Ehrenberg, Philip
    Robb, Merlin
    Jarman, Richard
    Bouckenooghe, Alain
    Michael, Nelson
    Chansinghakul, Danaya
    Thomas, Rasmi
    HUMAN IMMUNOLOGY, 2018, 79 : 29 - 29
12345